{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:49:34Z","timestamp":1793803774308,"version":"4.6.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jtha.2024.10.022","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:45:22Z","timestamp":1730814322000},"page":"731-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7559-2579","authenticated-orcid":false,"given":"Katrien M.J.","family":"Devreese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-139X","authenticated-orcid":false,"given":"Maria Laura","family":"Bertolaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1718-5094","authenticated-orcid":false,"given":"D. Ware","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9596-1944","authenticated-orcid":false,"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-677X","authenticated-orcid":false,"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-6071","authenticated-orcid":false,"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-4585","authenticated-orcid":false,"given":"Thomas L.","family":"Ortel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-6793","authenticated-orcid":false,"given":"Denis","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-390X","authenticated-orcid":false,"given":"Hannah","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.10.022_bib1","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2024.10.022_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"Devreese","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib3","first-page":"2164","article-title":"Laboratory diagnosis of antiphospholipid syndrome: insights and hindrances","volume":"11","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.10.022_bib4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2024.10.022_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib6","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib7","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2024.10.022_bib8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1055\/a-1344-4271","article-title":"Clinical relevance of isolated lupus anticoagulant positivity in patients with thrombotic antiphospholipid syndrome","volume":"121","author":"Yin","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13075-022-02814-w","article-title":"Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study","volume":"24","author":"Qi","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jtha.2024.10.022_bib10","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/jth.15785","article-title":"Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.jtha.2023.04.001","article-title":"Added value of antiphosphatidylserine\/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"21","author":"Vandevelde","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib12","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/jth.14560","article-title":"Clinical and laboratory practice for lupus anticoagulant testing: an International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey","volume":"17","author":"Cohen","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib14","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1016\/j.jtha.2023.08.009","article-title":"Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay","volume":"21","author":"Moore","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1055\/s-0043-1776406","article-title":"Variable performance of lupus anticoagulant testing: the Australasian\/Asia-Pacific experience","volume":"50","author":"Favaloro","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib16","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/jth.15518","article-title":"Single or triple positivity for antiphospholipid antibodies in \u2018carriers\u2019 or symptomatic patients: untangling the knot","volume":"19","author":"Bertin","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/ijlh.14240","article-title":"Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients","volume":"46","author":"Moore","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.10.022_bib18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib19","first-page":"735","article-title":"Clinical management of thrombotic antiphospholipid syndrome","volume":"11","author":"Tumian","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.10.022_bib20","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/jth.14488","article-title":"Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon","volume":"17","author":"Frans","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12676","article-title":"Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants","volume":"6","author":"Favaloro","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib22","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/jth.14894","article-title":"Direct oral anticoagulant adsorption: impact on lupus anticoagulant testing-review of the literature and evaluation on spiked and patient samples","volume":"18","author":"De Kesel","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib23","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1111\/jth.15438","volume":"19","author":"Moore","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rth2.12264","article-title":"The effect of unfractionated heparin, enoxaparin and danaparoid on lupus anticoagulant testing. Can activated carbon eliminate false positive results?","volume":"4","author":"De Kesel","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/jth.13020","article-title":"Mixing studies in lupus anticoagulant testing are required at least in some type of samples","volume":"13","author":"Devreese","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/cclm-2016-0245","article-title":"Dilute Russell's viper venom time reagents in lupus anticoagulant testing: a well-considered choice","volume":"55","author":"Depreter","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.10.022_bib27","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.jtha.2023.06.020","volume":"21","author":"Cohen","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/jth.14669","article-title":"Lupus anticoagulant assay cut-offs vary between reagents even when derived from a common set of normal donor plasmas","volume":"18","author":"Moore","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib29","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/jth.13678","article-title":"Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study","volume":"15","author":"Tripodi","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ijlh.13818","article-title":"A\u00a0multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network","volume":"44","author":"Favaloro","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.10.022_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1182\/blood-2009-09-244426","article-title":"Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants","volume":"115","author":"Devreese","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.022_bib32","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/jth.14238","article-title":"Laboratory criteria for antiphospholipid syndrome: reply","volume":"16","author":"Devreese","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1751-553X.2012.01448.x","article-title":"Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome","volume":"34","author":"Van Hoecke","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.10.022_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0039-1679901","article-title":"Detection of anti-cardiolipin and anti-beta2glycoprotein i antibodies differs between platforms without influence on association with clinical symptoms","volume":"119","author":"Chayoua","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtha.2024.10.022_bib36","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/bloodadvances.2021005205","article-title":"A\u00a0systematic review of the association between anti-beta-2 glycoprotein I antibodies and APS manifestations","volume":"5","author":"Jiang","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.10.022_bib37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jth.12537","article-title":"Subcommittee on Lupus Anticoagulant\/Phospholipid\/Dependent Antibodies. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH","volume":"12","author":"Devreese","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-0043-1776318","article-title":"Classification criteria for the antiphospholipid syndrome: not the same as diagnostic criteria for antiphospholipid syndrome","volume":"50","author":"Favaloro","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jtha.2023.12.019","article-title":"Antiphospholipid antibody solid phase-based assays: problems and proposed solutions for the 2023 ACR\/EULAR classification criteria for antiphospholipid syndrome","volume":"22","author":"Huisman","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jth.13560","article-title":"A\u00a0multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system","volume":"15","author":"Devreese","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.thromres.2006.07.014","article-title":"Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-glycoprotein I activity","volume":"120","author":"Pengo","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.022_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0032-1311990","article-title":"Internal quality control and external quality assurance in testing for antiphospholipid antibodies: part I--anticardiolipin and anti-beta2-glycoprotein I antibodies","volume":"38","author":"Favaloro","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071402","article-title":"Variability in exposure of epitope G40-R43 of domain I in commercial anti-beta2-glycoprotein I IgG ELISAs","volume":"8","author":"Pelkmans","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2024.10.022_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jth.12537","volume":"12","author":"Devreese","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib45","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jth.14261","article-title":"Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-beta2glycoprotein I antibody detection assays","volume":"16","author":"Chayoua","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib46","article-title":"Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome","volume":"4","author":"Devreese","year":"2021","journal-title":"J\u00a0Transl Autoimmun"},{"key":"10.1016\/j.jtha.2024.10.022_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1515\/cclm-2020-0995","article-title":"Development of a certified reference material for anti-\u03b22-glycoprotein I IgG \u2013 commutability studies","volume":"59","author":"Monogioudi","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.10.022_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0037-1612904","article-title":"Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins","volume":"85","author":"Rampazzo","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jth.14682","article-title":"Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: a multicenter multiplatform study","volume":"18","author":"Yin","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib50","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/art.39187","article-title":"Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against beta2 -glycoprotein i domain 1 and domain 4\/5: ratio of anti-domain 1 to anti-domain 4\/5 as a useful new biomarker for antiphospholipid syndrome","volume":"67","author":"Andreoli","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtha.2024.10.022_bib51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0042-1744364","article-title":"Solid phase assays for antiphospholipid antibodies","volume":"48","author":"Devreese","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ijlh.12466","article-title":"Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies","volume":"38","author":"Montaruli","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.10.022_bib53","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/keaa203","article-title":"EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies","volume":"60","author":"Pregnolato","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2024.10.022_bib54","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1136\/ard-2023-225074","article-title":"Response to: correspondence on 'ACR\/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers","volume":"83","author":"Barbhaiya","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2024.10.022_bib55","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.15585","article-title":"Semiquantitative interpretation of anticardiolipin and antibeta2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcp\/94.4.476","article-title":"Special report. The second international anti-cardiolipin standardization workshop\/the Kingston Anti-Phospholipid Antibody Study (KAPS) group","volume":"94","author":"Harris","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2024.10.022_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/antib5020014","article-title":"A\u00a0Clinical approach for defining the threshold between low and medium anti-cardiolipin antibody levels for QUANTA flash assays","volume":"5","author":"Lakos","year":"2016","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.jtha.2024.10.022_bib58","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jtha.2024.04.016","volume":"22","author":"Vandevelde","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jth.14633","article-title":"The (non-)sense of detecting anti-cardiolipin and anti-beta2glycoprotein I IgM antibodies in the antiphospholipid syndrome","volume":"18","author":"Chayoua","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib60","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jth.13379","article-title":"IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis","volume":"14","author":"Kelchtermans","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib61","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.autrev.2019.03.005","article-title":"(IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis","volume":"18","author":"Pastori","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtha.2024.10.022_bib62","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1161\/STROKEAHA.118.023021","article-title":"Antiphospholipid syndrome with isolated isotype M anticardiolipin and\/or anti-B2GPI antibody is associated with stroke","volume":"49","author":"Urbanski","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.10.022_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102395","article-title":"Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"18","author":"Chock","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtha.2024.10.022_bib64","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1160\/TH04-12-0839","article-title":"Antibody profiles for the diagnosis of antiphospholipid syndrome","volume":"93","author":"Pengo","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib65","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/09612033211014248","article-title":"Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset","volume":"30","author":"Elkhalifa","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2024.10.022_bib66","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1055\/s-0040-1714653","article-title":"Is there an additional value in detecting anticardiolipin and anti-beta2 glycoprotein I IgA antibodies in the antiphospholipid syndrome?","volume":"120","author":"Chayoua","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2141.2006.06283.x","article-title":"A\u00a0human monoclonal antiprothrombin antibody is thrombogenic in\u00a0vivo and upregulates expression of tissue factor and E-selectin on endothelial cells","volume":"135","author":"Vega-Ostertag","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.10.022_bib68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1055\/s-0038-1646476","article-title":"Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin","volume":"66","author":"Bevers","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1160\/TH13-06-0509","article-title":"Anti-prothrombin (aPT) and anti-phosphatidylserine\/prothrombin (aPS\/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review","volume":"111","author":"Sciascia","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib70","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/s-0040-1705115","article-title":"Antiphosphatidylserine\/prothrombin antibodies: an update on their association with clinical manifestations of antiphospholipid syndrome","volume":"120","author":"Radin","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2022.04.021","article-title":"Prevalence of aphosphatidylserine\/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"214","author":"Zhu","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.022_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1160\/TH12-07-0527","article-title":"Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS\/PT) in patients with and without lupus anticoagulant","volume":"109","author":"Bertolaccini","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib73","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/jth.12014","article-title":"Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities","volume":"10","author":"Sciascia","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib74","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/rheumatology\/kev226","article-title":"Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review","volume":"54","author":"Rodr\u00edguez-Garc\u00eda","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2024.10.022_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107034","article-title":"Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome","volume":"32","author":"Est\u00e9vez","year":"2023","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jtha.2024.10.022_bib76","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12026-021-09208-1","article-title":"Cerebrovascular events in patients with isolated anti-phosphatidyl-serine\/prothrombin antibodies","volume":"69","author":"Radin","year":"2021","journal-title":"Immunol Res"},{"key":"10.1016\/j.jtha.2024.10.022_bib77","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/jth.15792","article-title":"Anti-phosphatidylserine prothrombin antibodies as a predictor of the lupus anticoagulant in an all-comer population","volume":"20","author":"Pham","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib78","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1538-7836.2007.02454.x","article-title":"Participating Centres of Italian Federation of Thrombosis Centres (FCSA). Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples","volume":"5","author":"Pengo","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib79","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1111\/jth.15026","article-title":"Additional laboratory tests to improve on the diagnosis of antiphospholipid syndrome: response from Pengo","volume":"18","author":"Pengo","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib80","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/jth.14896","article-title":"Additional laboratory tests to improve on the diagnosis of antiphospholipid syndrome","volume":"18","author":"Pengo","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib81","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1016\/j.jtha.2023.06.033","article-title":"Close link between antiphosphatidylserine\/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody-positive subjects","volume":"21","author":"Pontara","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.741589","article-title":"A\u00a0novel ELISA assay for the detection of anti-prothrombin antibodies in antiphospholipid syndrome patients at high risk of thrombosis","volume":"12","author":"Chinnaraj","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.10.022_bib83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.thromres.2013.12.001","article-title":"Validation of a commercially available kit to detect anti-phosphatidylserine\/prothrombin antibodies in a cohort of systemic lupus erythematosus patients","volume":"133","author":"Sciascia","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.022_bib84","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.022_bib85","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2005-05-1943","article-title":"Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change","volume":"107","author":"de Laat","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.022_bib86","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-1-0716-3175-1_21","article-title":"Laboratory testing for non-criteria antiphospholipid antibodies: antibodies toward the domain I of beta2-glycoprotein I (aDI)","volume":"2663","author":"Devreese","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtha.2024.10.022_bib87","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/art.30633","article-title":"Immune responses against domain I of beta(2)-glycoprotein I are driven by conformational changes: domain I of beta(2)-glycoprotein I harbors a cryptic immunogenic epitope","volume":"63","author":"de Laat","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtha.2024.10.022_bib88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2018.02.002","article-title":"Beyond thrombosis: anti-beta2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome","volume":"90","author":"Chighizola","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jtha.2024.10.022_bib89","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/jth.13389","article-title":"Role of anti-domain 1-beta2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome","volume":"14","author":"De Craemer","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib90","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.autrev.2018.06.011","article-title":"The clinical value of assays detecting antibodies against domain I of beta2-glycoprotein I in the antiphospholipid syndrome","volume":"17","author":"Yin","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtha.2024.10.022_bib91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2017.02.019","article-title":"Clinical significance of anti-domain 1 beta2-glycoprotein I antibodies in antiphospholipid syndrome","volume":"153","author":"Iwaniec","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.022_bib92","first-page":"1242","article-title":"Anti-domain I beta2-glycoprotein I antibodies and activated protein C resistance predict thrombosis in antiphospholipid syndrome: TAC(I)T study","volume":"5","author":"Zuily","year":"2020","journal-title":"J\u00a0Appl Lab Med"},{"key":"10.1016\/j.jtha.2024.10.022_bib93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/STROKEAHA.119.027348","article-title":"Circulating circular RNAs as biomarkers for the diagnosis and prediction of outcomes in acute ischemic stroke","volume":"51","author":"Zuo","year":"2020","journal-title":"Stroke"},{"issue":"Supplement 1","key":"10.1016\/j.jtha.2024.10.022_bib94","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ijlh.14268","article-title":"Noncriteria antiphospholipid antibodies in antiphospholipid syndrome","volume":"46","author":"Devreese","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.10.022_bib95","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib96","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1177\/0961203314545410","article-title":"Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study","volume":"23","author":"Mustonen","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2024.10.022_bib97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0961203316657433","article-title":"Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity","volume":"26","author":"Yelnik","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2024.10.022_bib98","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.022_bib99","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jth.12264","article-title":"Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile","volume":"11","author":"Pengo","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jth.15158","article-title":"Trial of Rivaroxaban in Antiphospholipid Syndrome (TRAPS): two-year outcomes after the study closure","volume":"19","author":"Pengo","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib101","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/jth.14551","article-title":"Antiphosphatidylserine\/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome","volume":"17","author":"Z\u0105bczyk","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib102","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0961203317751644","article-title":"Antiphosphatidylserine\/prothrombin (aPS\/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome","volume":"27","author":"Kopytek","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2024.10.022_bib103","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/10408363.2024.2305121","article-title":"Lipid-binding antiphospholipid antibodies: significance for pathophysiology and diagnosis of the antiphospholipid syndrome","volume":"61","author":"M\u00fcller-Calleja","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jtha.2024.10.022_bib104","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2018.198119","article-title":"New insight into antiphospholipid syndrome: antibodies to beta2glycoprotein I-domain 5 fail to induce thrombi in rats","volume":"104","author":"Durigutto","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.10.022_bib105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-0037-1601331","article-title":"Laboratory diagnostics of antiphospholipid syndrome","volume":"44","author":"Pengo","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.10.022_bib106","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtha.2024.10.022_bib107","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2018.03.008","article-title":"Clinical and laboratory characteristics of isolated lupus anticoagulants","volume":"165","author":"Mattia","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.022_bib108","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1182\/blood-2014-11-611129","article-title":"Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)","volume":"125","author":"Gebhart","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.10.022_bib109","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/ijlh.13094","article-title":"Extended persistence of antiphospholipid antibodies beyond the 12-week time interval: association with baseline antiphospholipid antibodies titers","volume":"41","author":"Devignes","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.10.022_bib110","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.39668","article-title":"Brief report: changes in antiphospholipid antibody titers during pregnancy: effects on pregnancy outcomes","volume":"68","author":"Yelnik","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtha.2024.10.022_bib111","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/hematology.2019000046","article-title":"Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome","volume":"2019","author":"Petri","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2024.10.022_bib112","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.18295\/2075-0528.1622","article-title":"Fluctuation in the levels of immunoglobulin M and immunoglobulin G antibodies for cardiolipin and beta2-glycoprotein among healthy pregnant women","volume":"14","author":"Al-Balushi","year":"2014","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.jtha.2024.10.022_bib113","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1373\/clinchem.2016.265900","article-title":"Estimates of within-subject biological variation of protein C, antithrombin, protein S free, protein S activity, and activated protein C resistance in pregnant women","volume":"63","author":"Kristoffersen","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtha.2024.10.022_bib114","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/art.42459","article-title":"Fluctuation of anti-domain 1 and anti-beta(2) -glycoprotein I antibody titers over time in patients with persistently positive antiphospholipid antibodies","volume":"75","author":"Chighizola","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtha.2024.10.022_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1075121","article-title":"Application of the thrombin generation assay in patients with antiphospholipid syndrome: a systematic review of the literature","volume":"10","author":"Gehlen","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.10.022_bib116","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.thromres.2021.05.008","article-title":"Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence","volume":"203","author":"de Laat-Kremers","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.10.022_bib117","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/bloodadvances.2023011938","article-title":"Thrombin-driven neural net diagnoses the antiphospholipid syndrome without the need for interruption of anticoagulation","volume":"8","author":"de Laat-Kremers","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.10.022_bib118","first-page":"40","article-title":"An integrated soft computing approach to Hughes syndrome risk assessment","volume":"41","author":"Vilhena","year":"2017","journal-title":"J\u00a0Med Syst"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362400638X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362400638X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T02:43:50Z","timestamp":1769913830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362400638X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S153878362400638X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.022","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}